Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.910
-0.120 (-5.91%)
Sep 11, 2025, 11:07 AM - Market open
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $49.69 million as of September 11, 2025. Its market cap has decreased by -43.67% in one year.
Market Cap
49.69M
Enterprise Value
72.73M
1-Year Change
-43.67%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $49.69M, a decrease of -85.64%. That is a compound annual growth rate of -36.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 52.81M | -34.07% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.08B |
| Johnson & Johnson | 426.47B |
| AbbVie | 370.54B |
| UnitedHealth Group | 315.65B |
| AstraZeneca | 251.31B |
| Novartis AG | 249.66B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.67B |